Is BPC-157 legal in the EU?

BPC-157 has no marketing authorisation in the EU, so it may not be sold as a medicine. It is on the WADA Prohibited List (category S0). More: BPC-157 in Europe.

Is retatrutide approved in Europe?

No. Retatrutide is in phase 3 clinical trials and has no marketing authorisation in the EU. More: Retatrutide in Europe.

Can I buy semaglutide without a prescription in the EU?

No. Semaglutide is a prescription-only medicine in the EU. Websites offering it without a prescription are not legal sources.

GHK-Cu is a permitted cosmetic ingredient in the EU ("Copper Tripeptide-1"). It is not an approved medicine.

Are peptides legal in Europe? EU rules explained

Q: Are peptides legal in Europe?

Approved peptide medicines are legal on prescription. Peptides without a marketing authorisation may not be sold as medicines; they are traded as reference material for laboratory research, and national rules on import, possession and use differ.

Short answer: it depends on the substance and on how it is offered. Peptides that are approved medicines, such as semaglutide or tirzepatide, are available in the EU only on prescription. Peptides without a marketing authorisation, such as BPC-157, TB-500 or retatrutide, may not be sold as medicines. They are traded as reference material for laboratory research, and the rules on importing, possessing and using them differ between EU countries. Athletes face a separate set of rules: many peptides are on the WADA Prohibited List.

What decides whether a peptide is legal

Four questions decide how a peptide is treated in the EU:

Is it an approved medicine? Then it is sold through pharmacies, usually on prescription.
Is it offered as a medicine? A product presented as treating or preventing disease, or meant to change body functions, is a medicinal product under EU law, whatever the seller calls it.
Is it a cosmetic ingredient or a food? Then cosmetics or food law applies, with their own rules.
Is it used in sport? Then anti-doping rules apply in addition.

EU medicines law

The basic rules are set by Directive 2001/83/EC. It defines a medicinal product by presentation (offered as treating or preventing disease) or by function (used to restore, correct or modify physiological functions through a pharmacological, immunological or metabolic action). A medicinal product may only be placed on the market with a marketing authorisation.

Status	Examples	What it means
Approved medicine	semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide, oxytocin	pharmacy sale, mostly prescription-only
In clinical development	retatrutide, survodutide, cagrilintide	not approved; only available in clinical trials
No authorisation	BPC-157, TB-500, ipamorelin, CJC-1295, MOTS-c	may not be sold as medicines

Each member state enforces these rules through its own medicines act, for example the Arzneimittelgesetz in Germany and Austria, the Code de la santé publique in France, the Codice dei medicinali in Italy and the Geneesmiddelenwet in the Netherlands.

Research peptides

Peptides without an authorisation are sold in the EU as reference material for laboratory research, not for use in humans. What matters is how they are offered: a seller who promotes such a substance for personal use, with dosing instructions or health claims, is placing an unauthorised medicine on the market. Whether a private person may import or possess such a substance is decided nationally, and the rules differ.

Cosmetics and food supplements

Cosmetics: Some peptides are permitted cosmetic ingredients under the EU Cosmetics Regulation (EC) No 1223/2009, for example GHK-Cu as "Copper Tripeptide-1" or argireline as "Acetyl Hexapeptide-8".
Food supplements: New ingredients need an authorisation under the Novel Food Regulation (EU) 2015/2283. Nicotinamide riboside chloride is authorised; most research peptides are not food ingredients at all.

Peptides in sport

The World Anti-Doping Agency lists growth hormone, GHRH analogues, ghrelin mimetics (GHRPs), IGF-1, mechano growth factors and thymosin beta-4 derivatives such as TB-500 in category S2, and BPC-157 in category S0 (non-approved substances). Several EU countries go further and make doping offences a criminal matter, for example Germany (Anti-Doping-Gesetz), Austria (Anti-Doping-Bundesgesetz 2021), France (Code du sport) and Italy (Law 376/2000).

Buying from outside the EU

Shipments from outside the EU go through customs, and authorities can stop unauthorised medicines. The EU Falsified Medicines Directive (2011/62/EU) adds safety features for medicines and a common logo for legal online pharmacies; a website selling prescription medicines without that logo and without a prescription is not a legal source. Buying from a supplier inside the EU avoids customs clearance for research material and gives you an invoice with VAT and a contact within EU law; see Peptides from the EU.

What this means in practice

Approved peptides (semaglutide, tirzepatide): only with a prescription, from a pharmacy.
Research peptides: only from suppliers that sell them as laboratory reference material, with a lab report for every batch, and never for self-use. How to check that report: How to read a peptide COA.
Athletes: treat every peptide on the WADA list as banned, in and out of competition.

This guide is general information, not legal advice. For a specific case, ask a lawyer in your country. More on Germany: Sind Peptide legal in Deutschland? (German).